Tandem Diabetes Care (TNDM) Short-term Investments (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Short-term Investments came in at $390.9 million in Q1 2026, up 24.08% YoY from $315.1 million in Q1 2025, and up 93.5% on a QoQ basis from $202.0 million in Q4 2025.
Tandem Diabetes Care (TNDM) Short-term Investments (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Short-term Investments data on file, last reported at $390.9 million in Q1 2026.
- Quarterly Short-term Investments rose 24.08% year-over-year to $390.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $390.9 million (up 24.08% YoY) and the FY2025 annual result came in at $202.0 million, down 45.26% from the prior year.
- Short-term Investments advanced to $390.9 million in Q1 2026, from $202.0 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $541.7 million in Q1 2022 to a low of $202.0 million in Q4 2025.
- A 5-year average of $387.1 million and a median of $404.7 million in 2024 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2022 — Short-term Investments soared 37.96% — and 2025, when it slumped 46.46%.
- Tracing TNDM's Short-term Investments over 5 years: stood at $444.4 million in 2022, then dropped by 7.95% to $409.0 million in 2023, then dropped by 9.77% to $369.1 million in 2024, then slumped by 45.26% to $202.0 million in 2025, then soared by 93.5% to $390.9 million in 2026.
- The last three Short-term Investments figures came in at $390.9 million (Q1 2026), $202.0 million (Q4 2025), and $227.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.55 Bn | 1.10 Bn | 144.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 393.18 Mn |
| Mar 31, 2026 | 390.93 Mn |
| Dec 31, 2025 | 202.03 Mn |
| Sep 30, 2025 | 227.16 Mn |
| Jun 30, 2025 | 251.25 Mn |
| Mar 31, 2025 | 315.05 Mn |
| Dec 31, 2024 | 369.10 Mn |
| Sep 30, 2024 | 424.27 Mn |
| Jun 30, 2024 | 404.72 Mn |
| Mar 31, 2024 | 408.83 Mn |
| Dec 31, 2023 | 409.04 Mn |
| Sep 30, 2023 | 418.55 Mn |
| Jun 30, 2023 | 376.50 Mn |
| Mar 31, 2023 | 391.83 Mn |
| Dec 31, 2022 | 444.38 Mn |
| Sep 30, 2022 | 484.94 Mn |
| Jun 30, 2022 | 520.37 Mn |
| Mar 31, 2022 | 541.71 Mn |
| Dec 31, 2021 | 552.63 Mn |
| Sep 30, 2021 | 482.62 Mn |